Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-15-07 | Hyperthyroidism | ETA2023

Immunogenetics markers of graves’ disease relapse after antithyroid treatment

Zhilina Ekaterina , Drogashevskaya Natalia , Martirosian Narine , Petunina Nina

Introduction: The choice of treatment for GravesÂ’ disease (GD) requires a comprehensive assessment of the patientÂ’s condition and the risk of recurrence. The aim of our study was to evaluate the association of immunological and genetic markers with GD recurrence after antithyroid treatment.Methods: We conducted a case-control study. The study included 63 patients with GD who received antithyroid treatment. After at least 12 months of withdrawal...